Skip to main navigation
Skip to search
Skip to main content
UTMB Health Research Expert Profiles Home
Help & FAQ
Link opens in a new tab
Search content at UTMB Health Research Expert Profiles
Home
Experts
Departments
Equipment
Projects/Grants
Publications
Activities
Press/Media
Honors
Impacts
Future of escherichia coli research in Latin America
Tânia A.T. Gomes
, Cristina Ibarra
, Fernando Navarro-Garcia
, Marina Palermo
, Valeria Prado
, Marta Rivas
,
Alfredo G. Torres
Microbiology And Immunology
Research output
:
Chapter in Book/Report/Conference proceeding
›
Chapter
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Future of escherichia coli research in Latin America'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Latin America (LATAM)
100%
Escherichia Coli
100%
Early Diagnosis
33%
Diarrhea
33%
Diarrheal Disease
33%
Re-emerging
33%
Human Disease
33%
Atypical Hemolytic Uremic Syndrome (aHUS)
33%
Cause of Death
33%
Effective Treatment
33%
Novel Treatments
33%
Latin American Countries
33%
Atypical EPEC
33%
Antimicrobial Resistance
33%
Human Reservoir
33%
Major Diagnostic Categories
33%
Cause of Illness
33%
21st Century
33%
Epidemiological Survey
33%
Detection Efficiency
33%
Asymptomatic Carriage
33%
Carriage Rate
33%
EHEC O157
33%
Pathogenic E. Coli
33%
Diarrheagenic Escherichia Coli
33%
Medicine and Dentistry
Escherichia coli
100%
Diseases
100%
Early Diagnosis
33%
Diarrhea
33%
Antibiotic Resistance
33%
Serotype
33%
Pathogenic Escherichia Coli
33%
Diarrheagenic Escherichia Coli
33%
Atypical Hemolytic Uremic Syndrome
33%
Effective Treatment
33%
Arts and Humanities
Latin America
100%
Latin American
33%
Likelihood
33%
Capabilities
33%
21C
33%
Immunology and Microbiology
Escherichia coli
100%
Pathogenic Escherichia Coli
33%
Serotype
33%
Diarrheagenic Escherichia Coli
33%
Antibiotic Resistance
33%
Veterinary Science and Veterinary Medicine
Escherichia coli
100%
Diseases
60%
Hemolytic-Uremic Syndrome
20%
Antibiotic Resistance
20%